Warfarin resistance in a French strain of rats

Journal of Biochemical and Molecular Toxicology

Volumn 19, Issue 6, 2006, Pages 379-385

  Lasseur, Romain ^a   Longin Sauvageon, Christiane ^a   Videmann, Bernadette ^a   Billeret, Mikaëline ^b   Berny, Philippe ^a   Benoit, Etienne ^a  

^a VETAGRO SUP   (France)

^b LIPHA   (France)

Author keywords

Anticoagulant; Kinetic parameters; Rattus norvegicus; Resistance; VKOR; VKORC1

Indexed keywords

ANTICOAGULANT AGENT; MENADIONE EPOXIDE; MESSENGER RNA; PHENYLALANINE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); RODENTICIDE; TYROSINE; UNCLASSIFIED DRUG; VITAMIN K EPOXIDE REDUCTASE 1; WARFARIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG RESISTANCE; ENZYME ACTIVITY; ENZYME KINETICS; ENZYME SUBUNIT; EUROPE; FRANCE; GENE EXPRESSION; GENE MUTATION; GENETIC RESISTANCE; NONHUMAN; NUCLEOTIDE SEQUENCE; RAT; RAT STRAIN;

ANIMALIA; RATTUS NORVEGICUS;

EID: 31344446859     PISSN: 10956670     EISSN: 10990461     Source Type: Journal    
DOI: 10.1002/jbt.20104     Document Type: Article

References (26)

1. Suttie J. Vitamin K. In: Deluca H, editor, Handbook of lipid research. New York: Plenum; 1978. pp 3-16.
2. Cain D, Hutson S, Wallin R. Warfarin resistance is associated with a protein component of the vitamin K 2,3-epoxide reductase enzyme complex in rat liver. Thromb Haemostasis 1998;80:128-133.
3. Boyle M. Case of apparent resistance of Rattus norvegicus Berkenhout to anticoagulant poisons. Nature 1960;188:517-525.
4. Lund M. The resistance to anticoagulants. Dan Pest Infest Lab 1967;47:611-618.
5. Telle H. Resistance to warfarin of the brown rat Rattus norvegicus in Germany. WHO Bull 1971;45:331-334.
6. Jackson W, Kaukeinen D. Resistance of wild Norway rats in North Carolina to warfarin rodenticide. Science 1972;176:1343-1344.
7. Greaves J, Ayres P. Warfarin resistance and the vitamin K requirement in the rat. Lab Animal 1973;7:141-148.
8. Greaves J, Ayres P. Heritable resistance to warfarin in rats. Nature 1967;215:877-878.
9. Kohn M, Pelz H-J. A gene-anchored map position of the rat warfarin-resistance locus, Rw, and its orthologs in mice and humans. Blood 2000;96:1996-1997.
10. Kohn M, Pelz H-J, Wayne R. Locus-specific genetic differentiation at Rw among warfarin-resistant rat (Rattus norvegicus) populations. Genetics 2003;164:1055-1070.
11. Thijssen H, Janssen C, Mosterd J. Warfarin resistance: Biochemical evaluation of a warfarin-resistant wild brown rat. Biochem Pharmacol 1989;38:3129-3132.
12. Rost S, Fregin A, Ivaskevicius V, Conzelmann E, Hörtnagel K, Pelz H-J, Lappegard K, Seifried E, Scharrer I, Tuddenham EGD, Müller CR, Strom TM, Oldenburg J. Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2. Nature 2004;427:537-541.
13. Pelz J, Rost S, Hünerberg M, Fregin A, Heiberg A-C, Baert K, MacNicoll A, Prescott C, Walter A-S, Oldenburg J, Müller C. The genetic basis of resistance to anticoagulants in rodents. Genetics 2005;170:1839-1847.
14. EPPO. Guideline for the evaluation of resistance to plant protection products: Testing rodents for resistance to anticoagulant rodenticides. EPPO Bull 1995;25:575-593.
15. Moroni P, Longin-Sauvageon C, Benoit E. The flavin-containing monooxygenase in rat liver: Evidence for the expression of a second form different from FMO1. Biochem Biophys Res Commun 1995;212:820-826.
16. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
17. Tishler M, Fieser LF, Wendler NL. Hydro, oxido and other derivatives of vitamin K1 related compounds. J Am Chem Soc 1940;62:2866-2871.
18. Thijssen H. Vitamin K epoxide reductase of Scottish resistance genes is not irreversibly blocked by warfarin. Biochem Pharmacol 1987;36:2753-2757.
19. Thijssen H, Baars L. Microsomal warfarin binding and vitamin K 2,3-epoxide reductase. Biochem Pharmacol 1989;38:1115-1120.
20. Misenheimer TM, Suttie JW. Warfarin resistance in a Chicago strain of rats. Biochem Pharmacol 1990;40:2079-2084.
21. MacNicoll AD, Nadian AK, Townsend MG. Inhibition by warfarin of liver microsomal vitamin K-reductase in warfarin-resistant and susceptible rats. Biochem Pharmacol 1983;33:1331-1336.
22. Vermeer C, Soute B, Aalten M, Knapen M, Thijssen H. Vitamin K reductases in normal and in warfarin-resistant rats. Biochem Pharmacol 1988;37:2876-2878.
23. Markussen M, Heiberg A, Nielsen R, Leirs H. Vitamin K requirements in Danish anticoagulant-resistant Norway rats (Rattus norvegicus). Pest Manage Sci 2003;59:913-920.
24. Wallin R, Hutson SM, Cain D, Sweatt A, Sane DC. A molecular mechanism for genetic warfarin resistance in the rat. J Exp Biol 2001;15:2542-2548.
25. Wajih N, Sane DC, Hutson SM, Wallin R. The inhibitory effect of calumenin on the vitamin K-dependent -carboxylation system. Characterization of the system in normal and warfarin-resistant rats. Biochem Pharmacol 2004;279:25276-25283.
26. Goodstadt L, Ponting C. Vitamin K epoxide reductase: Homology, active site and catalytic mechanism. Trends Biochem Sci 2004;29:289-292.